Document is current

Article History

Received: 9 February 2022

Accepted: 8 September 2022

First Online: 16 December 2022

Declarations

:

: This study was reviewed and approved by the ethical committee of the Changzhou No. 2 People’s Hospital Affiliated to Nanjing Medical University (No. [2022] KY 116-01) and approved to exempt patients from informed consent. The reasons are as follows: our study does not interfere with patients, has no contact with patients, does not involve patients’ personal privacy, does not provide research results to patients, does not serve as auxiliary diagnostic basis, and has no risk to patients. It complies with the provisions of articles 33 and 39 of the measures for ethical review of biomedical research involving human beings (implemented since December 1, 2016) issued by our national health and Family Planning Commission, so it is allowed to exempt the patient from informed consent.This study only analyzed the previous laboratory test data of patients, did not contact with patients, did not pose a threat to the health of patients, and did not harm the interests of patients. On the premise of exempting patients from informed consent, our study is compliance with the Declaration of Helsinki. All authors declare that we will keep the information of all research objects strictly confidential and will not infringe the privacy of any research object. All authors declare that our study is compliance with the Declaration of Helsinki.

: Not applicable.

: The authors have no relevant financial or non-financial interests to disclose.